Brief: IRLAB's Mesdopetam IND Accepted By The US FDA

IRLAB Therapeutics AB

01/10/2020 07:36

Oct 1 (Reuters) - IRLAB Therapeutics AB  IRLABa.ST :
    * IRLAB'S MESDOPETAM IND ACCEPTED BY THE US FDA
    * PHASE IIB/III STUDY PREPARATIONS ARE PROGRESSING ACCORDING
TO
PLAN
    * OBJECTIVE IS TO START PATIENT RECRUITMENT DURING Q4 2020.

Source text for Eikon:  ID:nWkr67myVP 
Further company coverage:  IRLABa.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))